Results 271 to 280 of about 179,002 (365)

Scientific approaches to defining HPV vaccine‐induced protective immunity

open access: yesInternational Journal of Cancer, Volume 156, Issue 10, Page 1848-1857, 15 May 2025.
Abstract Seventeen years after the licensure of prophylactic human papillomavirus (HPV) L1 virus‐like‐particle vaccines, a defined antibody level that correlates with vaccine‐induced protection against HPV infections and associated neoplasia is missing.
Matti Lehtinen   +6 more
wiley   +1 more source

Immunohistochemical analysis of post-transfusion graft-versus-host disease by anti-HLA-monoclonal antibodies.

open access: bronze, 1988
Fumitaka Nishigaki   +5 more
openalex   +2 more sources

Prophylactic HPV vaccination in HPV‐related gynecologic cancers: European Society of Gynecological Oncology (ESGO) prevention committee opinion

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 169, Issue 2, Page 597-604, May 2025.
Abstract Many clinicians recommend that patients diagnosed with HPV‐related gynecologic cancers receive prophylactic HPV vaccination at the time of cancer diagnosis or after cancer treatment. In view of the large use of such practice, we aimed to assess the literature evidence supporting the use of prophylactic HPV vaccines after diagnosis or treatment
Nicolò Bizzarri   +9 more
wiley   +1 more source

Cytologic DNA methylation for managing minimally abnormal cervical cancer screening results

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objectives To explore the role of a DNA methylation assay for managing minimally abnormal cervical cancer screening results in a prospective cohort undergoing opportunistic cervical cancer screening. Methods In the cohort of the METHY2 and METHY3 screening studies of women undergoing opportunistic cervical cancer screening, cervical cytology ...
Xiao Shang   +8 more
wiley   +1 more source

Alterations and mechanistic insights of gut microbiota and its metabolites in type 2 diabetes mellitus and Alzheimer's disease

open access: yesiMetaOmics, EarlyView.
This narrative review uniquely addresses how gut microbiota‐derived metabolites mediate overlapping pathologies of insulin resistance, neuroinflammation, and amyloidogenesis in type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD), proposing a framework for dual therapeutic targeting.
Guangyi Xu   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy